Kai-Xuan Zeng

Identification of Antileukemic Compound From Ginger by Integrating UHPLC–MS, Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and In Vitro and In Vivo Experimental Validation

Findings provide the first evidence supporting ginger as a novel phytochemical resource for AML therapy and support Arctigenin as a promising antileukemic candidate, underscoring its potential for incorporation into food‐based or plant‐derived therapeutic strategies.